Serracor-NK: Peyronie's Disease and Systemic Enzymes
While not often openly discussed, sexual health is of the utmost importance to many people. Even the slightest variations in sexual organ function or appearance are usually noticed quickly, and a quick resolution of the abnormal is sought after. While conventional medicine works hard to keep up with the demands of this population, some conditions remain notoriously difficult to treat.
Peyronie’s disease is a scarring condition that results in deformity of the penis. When a penis affected by Peyronie’s disease is erect, it is usually bent or curved and painful. The exact cause is unknown, and may differ from case to case, but the end result is the same; microvascular damage to sensitive areas of the penis initiates an immune response to heal the area, but for some reason inflammation does not subside. Fibrin creates scar tissue that starts to form around the affected site, eventually forming a hard plaque that prevents the penis from achieving a full erection.
Current treatment options can involve extremely invasive and risky surgical procedures with no guarantee for effectiveness. Reducing inflammation and breaking up the scar tissue deposit should be obvious goals in treating this condition, and systemic enzymes may provide the means necessary.
Multiple enzymes have demonstrated their ability to assist in alleviating symptoms of Peyronie’s disease. Nattokinase has been studied extensively for its ability to reduce fibrin in the body and is shown to be more powerful than plasmin. Serrapeptase increases fibrin break down and removal plus also has anti-inflammatory effects. Bromelain contains protein-digesting enzymes that act on several steps in the process of fibrin break down to lower fibrin levels.
Those who have used systemic enzyme therapy in relation with this condition have found that taking a proactive and strong approach has given them greater success. By combining these powerful enzymes, systemic enzyme therapy that is maintained at therapeutic levels can provide a safe and natural alternative to addressing Peyronie’s disease.
Learn more about Serracor-NK today!
References:
1. Fujita M, Hong K, Ito Y, et al. Thrombolytic Effect of Nattokinase on a Chemically Induced Thrombosis Model in Rat. Biol Pharm Bull. 1995; 18(10):1387-1391.
2. Mazzone A, Catalani M, Costanzo M, et al. Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double-blind, randomized trial versus placebo. J Int Med Res. 1990; 18(5):379-88.
3. Fitzhugh DJ, Shan S, Dewhirst MW et al. Bromelain treatment decreases neutrophil migration to sites of inflammation. Clin Immunol. 2008; 128:66-74.